148 related articles for article (PubMed ID: 10683120)
1. Rosiglitazone approved for treatment of type 2 diabetes.
Miller JL
Am J Health Syst Pharm; 1999 Jul; 56(13):1292, 1294. PubMed ID: 10683120
[No Abstract] [Full Text] [Related]
2. Anticipated US approval for rosiglitazone and pioglitazone.
Diabetes Obes Metab; 1999 May; 1(3):181-2. PubMed ID: 11220298
[No Abstract] [Full Text] [Related]
3. Pharmacologic therapy for type 2 diabetes mellitus.
DeFronzo RA
Ann Intern Med; 2000 Jul; 133(1):73-4. PubMed ID: 10877745
[No Abstract] [Full Text] [Related]
4. Diabetes recall. Though Rezulin's withdrawal is a blow for some patients, there are ways to cope. Here's how.
Gorman C
Time; 2000 Apr; 155(13):94. PubMed ID: 11009709
[No Abstract] [Full Text] [Related]
5. The long Avandia endgame.
Mullard A
Lancet; 2011 Jul; 378(9786):113. PubMed ID: 21748869
[No Abstract] [Full Text] [Related]
6. FDA approves pioglitazone for diabetes.
Miller JL
Am J Health Syst Pharm; 1999 Sep; 56(17):1698. PubMed ID: 10512494
[No Abstract] [Full Text] [Related]
7. Rosiglitazone: a case of regulatory hubris.
Nissen SE
BMJ; 2013 Dec; 347():f7428. PubMed ID: 24335808
[No Abstract] [Full Text] [Related]
8. Thiazolidinediones: a comparative review of approved uses.
Sood V; Colleran K; Burge MR
Diabetes Technol Ther; 2000; 2(3):429-40. PubMed ID: 11467345
[TBL] [Abstract][Full Text] [Related]
9. Rosiglitazone: an agent from the thiazolidinedione class for the treatment of type 2 diabetes.
Cheng-Lai A; Levine A
Heart Dis; 2000; 2(4):326-33. PubMed ID: 11728276
[TBL] [Abstract][Full Text] [Related]
10. Rosiglitazone.
Goldstein BJ
Int J Clin Pract; 2000 Jun; 54(5):333-7. PubMed ID: 10954962
[TBL] [Abstract][Full Text] [Related]
11. From the Food and Drug Administration.
Henney JE
JAMA; 1999 Sep; 282(10):932. PubMed ID: 10485665
[No Abstract] [Full Text] [Related]
12. [First insulin sensitizer approved in Germany. Insulin resistance in type 2 diabetes can be treated].
MMW Fortschr Med; 2000 Sep; 142(36):50. PubMed ID: 11021073
[No Abstract] [Full Text] [Related]
13. Warner Lambert/Sankyo diabetes drug nears market.
Nat Biotechnol; 1997 Feb; 15(2):113. PubMed ID: 9035120
[No Abstract] [Full Text] [Related]
14. Rosiglitazone and type 2 diabetes mellitus.
Bragg T
Lancet; 2001 May; 357(9266):1451. PubMed ID: 11360960
[No Abstract] [Full Text] [Related]
15. Rosiglitazone for type 2 diabetes mellitus.
Med Lett Drugs Ther; 1999 Aug; 41(1059):71-3. PubMed ID: 10603986
[No Abstract] [Full Text] [Related]
16. Rosiglitazone monotherapy and type 2 diabetes.
Lawrence IG
Diabet Med; 2001 Nov; 18 Suppl 4():6-8. PubMed ID: 11989215
[No Abstract] [Full Text] [Related]
17. [Type II diabetes mellitus. Rosiglitazone is effective against insulin resistance].
Oberpichler-Schwenk H
Med Monatsschr Pharm; 1999 Sep; 22(9):288-9. PubMed ID: 10577070
[No Abstract] [Full Text] [Related]
18. Rosiglitazone and the FDA.
Joffe HV; Parks MH; Meyer RJ; Jenkins JK; Temple R
N Engl J Med; 2007 Oct; 357(17):1775-6; author reply 1777. PubMed ID: 17761586
[No Abstract] [Full Text] [Related]
19. Pioglitazone and rosiglitazone for diabetes.
Drug Ther Bull; 2001 Sep; 39(9):65-8. PubMed ID: 11586802
[TBL] [Abstract][Full Text] [Related]
20. Guidance on rosiglitazone for type 2 diabetes mellitus.
Matthews DR
Lancet; 2001 Feb; 357(9254):481. PubMed ID: 11273100
[No Abstract] [Full Text] [Related]
[Next] [New Search]